These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 28247846)

  • 1. Incidence of Device-Detected Atrial Fibrillation and Long-Term Outcomes in Patients With Hypertrophic Cardiomyopathy.
    van Velzen HG; Theuns DA; Yap SC; Michels M; Schinkel AF
    Am J Cardiol; 2017 Jan; 119(1):100-105. PubMed ID: 28247846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High Incidence of De Novo and Subclinical Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy and Cardiac Rhythm Management Device.
    Wilke I; Witzel K; Münch J; Pecha S; Blankenberg S; Reichenspurner H; Willems S; Patten M; Aydin A
    J Cardiovasc Electrophysiol; 2016 Jul; 27(7):779-84. PubMed ID: 27060297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic impact of newly detected atrial fibrillation in patients with hypertrophic cardiomyopathy following cardiac implantable electronic device implantation.
    Hayashi H; Iwasaki YK; Arai T; Mimuro R; Hachisuka M; Maru Y; Fujimoto Y; Oka E; Hagiwara K; Imori Y; Yamamoto T; Murata H; Yodogawa K; Takano H; Shimizu W
    Heart Vessels; 2021 May; 36(5):667-674. PubMed ID: 33221953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detecting Atrial Fibrillation in the Emergency Department in Patients with Cardiac Implantable Electronic Devices.
    Pugh M; Belott P; Greenwood KL; McNamee PL; Smith B; Craig TL; Mardekian J; Trocio J; Fanning D; Carda E
    J Emerg Med; 2019 Oct; 57(4):437-443. PubMed ID: 31506197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of stroke in patients with hypertrophic cardiomyopathy in stable sinus rhythm during long-term monitoring.
    Fumagalli C; Bonanni F; Beltrami M; Ruggieri R; Zocchi C; Tassetti L; Maurizi N; Berteotti M; Zampieri M; Argirò A; Lovero F; Tomberli A; di Bari M; Marchionni N; Pieragnoli P; Ricciardi G; Checchi L; Cappelli F; Fumagalli S; Olivotto I
    Int J Cardiol; 2023 Jun; 381():70-75. PubMed ID: 37061097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occurrence and Natural History of Clinically Silent Episodes of Atrial Fibrillation in Hypertrophic Cardiomyopathy.
    Rowin EJ; Orfanos A; Estes NAM; Wang W; Link MS; Maron MS; Maron BJ
    Am J Cardiol; 2017 Jun; 119(11):1862-1865. PubMed ID: 28395893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: atrial fibrillation type determines the success rate.
    Derejko P; Polańska M; Chojnowska L; Michałowska I; Wójcik A; Piotrowicz E; Lech A; Kłopotowski M; Baranowski R; Przybylski A; Bilińska M; Sierpiński R; Walczak F; Szumowski L
    Kardiol Pol; 2013; 71(1):17-24. PubMed ID: 23348529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stroke incidence in patients with cardiac implantable electronic devices remotely controlled with automatic alerts of atrial fibrillation. A sub-analysis of the HomeGuide study.
    Ricci RP; Vaccari D; Morichelli L; Zanotto G; Calò L; D'Onofrio A; Curnis A; Pisanò EC; Nangah R; Brieda M; Calzolari V; Melissano D; Rovai N; Gargaro A
    Int J Cardiol; 2016 Sep; 219():251-6. PubMed ID: 27340918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of atrial fibrillation on the clinical course of apical hypertrophic cardiomyopathy.
    Lee SE; Park JK; Uhm JS; Kim JY; Pak HN; Lee MH; Joung B
    Heart; 2017 Oct; 103(19):1496-1501. PubMed ID: 28428444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Significance and Risk of Atrial Fibrillation of Wolff-Parkinson-White Syndrome in Patients With Hypertrophic Cardiomyopathy.
    Song C; Guo Y; Zheng X; Lu J; Fang X; Wang S; Huang X
    Am J Cardiol; 2018 Nov; 122(9):1546-1550. PubMed ID: 30201118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of previously undiagnosed atrial fibrillation in patients with stroke risk factors and usefulness of continuous monitoring in primary stroke prevention.
    Ziegler PD; Glotzer TV; Daoud EG; Singer DE; Ezekowitz MD; Hoyt RH; Koehler JL; Coles J; Wyse DG
    Am J Cardiol; 2012 Nov; 110(9):1309-14. PubMed ID: 22819433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of new atrial fibrillation in patients with cardiac implanted electronic devices and factors associated with transition to higher device-detected atrial fibrillation burden.
    Boriani G; Glotzer TV; Ziegler PD; De Melis M; Mangoni di S Stefano L; Sepsi M; Landolina M; Lunati M; Lewalter T; Camm AJ
    Heart Rhythm; 2018 Mar; 15(3):376-383. PubMed ID: 29122724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term clinical course after catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy.
    Higuchi S; Ejima K; Minami Y; Ooyabu K; Iwanami Y; Yagishita D; Shoda M; Hagiwara N
    Heart Vessels; 2019 Mar; 34(3):527-537. PubMed ID: 30255478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rationale and design of a prospective study of the clinical significance of atrial arrhythmias detected by implanted device diagnostics: the TRENDS study.
    Glotzer TV; Daoud EG; Wyse DG; Singer DE; Holbrook R; Pruett K; Smith K; Hilker CE
    J Interv Card Electrophysiol; 2006 Jan; 15(1):9-14. PubMed ID: 16680544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective randomized study to assess the efficacy of site and rate of atrial pacing on long-term progression of atrial fibrillation in sick sinus syndrome: Septal Pacing for Atrial Fibrillation Suppression Evaluation (SAFE) Study.
    Lau CP; Tachapong N; Wang CC; Wang JF; Abe H; Kong CW; Liew R; Shin DG; Padeletti L; Kim YH; Omar R; Jirarojanakorn K; Kim YN; Chen MC; Sriratanasathavorn C; Munawar M; Kam R; Chen JY; Cho YK; Li YG; Wu SL; Bailleul C; Tse HF;
    Circulation; 2013 Aug; 128(7):687-93. PubMed ID: 23868858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silent ischaemic brain lesions related to atrial high rate episodes in patients with cardiac implantable electronic devices.
    Benezet-Mazuecos J; Rubio JM; Cortés M; Iglesias JA; Calle S; de la Vieja JJ; Quiñones MA; Sanchez-Borque P; de la Cruz E; Espejo A; Farré J
    Europace; 2015 Mar; 17(3):364-9. PubMed ID: 25336664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of cardiac electronic implantable device in the stratification and management of embolic risk of silent atrial fibrillation: are all atrial fibrillations created equal?
    Di Cori A; Lilli A; Zucchelli G; Zaca V
    Expert Rev Cardiovasc Ther; 2018 Mar; 16(3):175-181. PubMed ID: 29431527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness and safety of transcatheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy.
    Gaita F; Di Donna P; Olivotto I; Scaglione M; Ferrero I; Montefusco A; Caponi D; Conte MR; Nistri S; Cecchi F
    Am J Cardiol; 2007 Jun; 99(11):1575-81. PubMed ID: 17531584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between ventricular pacing and persistent atrial fibrillation in patients indicated to elective pacemaker replacement: Results of the Prefer for Elective Replacement MVP (PreFER MVP) randomized study.
    Ricci RP; Botto GL; Bénézet JM; Nielsen JC; De Roy L; Piot O; Quesada A; Quaglione R; Vaccari D; Mangoni L; Grammatico A; Kozák M;
    Heart Rhythm; 2015 Nov; 12(11):2239-46. PubMed ID: 26142300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of atrial high-rate episodes on the risk of future stroke.
    Nakano M; Kondo Y; Nakano M; Kajiyama T; Hayashi T; Ito R; Takahira H; Kobayashi Y
    J Cardiol; 2019 Aug; 74(2):144-149. PubMed ID: 30728105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.